Physician profile
Sadaf Saghier
NPI 1346404159
$549.49
in general payments reported to CMS, 2019-2025
13 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.52 · 2020: $29.08 · 2021: $99.92 · 2022: $105 · 2023: $74.87 · 2024: $27.06 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $240.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $127.98 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.82 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $61.14 | 2025 | Bylvay |
| Takeda Pharmaceuticals U.S.A., INC. | $56.66 | 2025 | Gattex |
| Evoke Pharma, INC. | $54.35 | 2021-2022 | |
| Qol Medical, LLC | $27.06 | 2024 | Sucraid |
| Alexion Pharmaceuticals, INC. | $23.12 | 2019 | |
| Mirum Pharmaceuticals, INC. | $21.01 | 2025 | Livmarli |
| Abbvie INC. | $18.44 | 2022 | |
| Braintree Laboratories, INC. | $17.75 | 2021 | |
| Redhill Biopharma INC. | $16.94 | 2022 | |
| Celgene Corporation | $13.67 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $13.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sadaf Saghier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.